[Severe complications following the intrathecal administration of a methylene blue solution].
Very serious complications are reported following intrathecal injection of methylene blue. The clinical indication was to assess spontaneous rhinoliquorrhoe. It is now generally agreed that intrathecal application of dyestuff solutions, especially of methylene blue, is no longer permissible.